Wenjian Guo

492 citations
29 papers · 347 indexed · h-index 11
Topics
Histone Deacetylase Inhibitors Research (7 papers)Acute Myeloid Leukemia Research (6 papers)Protein Degradation and Inhibitors (4 papers)
Partner nations
ChinaUnited States

In The Last Decade

Wenjian Guo

28 papers receiving 343 citations

Peers

Wenjian Guo
Comparison fields: 5 of 88
  • Molecular Biology 157
  • Hematology 78
  • Cancer Research 76
  • Immunology 45
  • Social Psychology 43
Replace Neili Xu with:
Neili Xu China
Yuichi Matsuno Japan
Yening Zhang China
Maher Chaar United States
Hussein Mahagna Israel
Suzhen Liu China
Cheryl L. Peters United States
Jiayi Hu China
Khushboo Sheth United States
Rodrigo Sánchez-Bayona Spain
Wenjian Guo relative to Neili Xu China Neili Xu's profile →
Citations per field
00.5×
Neili Xu · 1×
Citations per year

Countries citing papers authored by Wenjian Guo

Since Specialization
Citations

This map shows the geographic impact of Wenjian Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjian Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjian Guo more than expected).

Fields of papers citing papers by Wenjian Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjian Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjian Guo. The network helps show where Wenjian Guo may publish in the future.

Co-authorship network of co-authors of Wenjian Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjian Guo. A scholar is included among the top collaborators of Wenjian Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjian Guo. Wenjian Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 17
3 6
4 15
5 4
6 71
7 6
8 14
9 8
10 2
11 5
12 9
13 2
14 15
15 16
16 6
17 15
18 3
19 19
20
[Clinical efficiency of tanshinone IIA-sulfonate in treatment of liver fibrosis of advanced schistosomiasis].
9

About Wenjian Guo

Wenjian Guo is a scholar working on Hematology, Physiology and Molecular Biology, having authored 29 papers that have together received 347 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (7 papers), Acute Myeloid Leukemia Research (6 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Hematology (78 citations), Cancer Research (76 citations) and Health (26 citations). Wenjian Guo has collaborated with scholars based in China and United States. Frequent co-authors include He Huang, Lianlian Zhu, Xiaohai Zhou, Ying Lin, Lei Shi, Hong Wang, Limin Jin, Yunhua Bao, Ying Lin and Ying Lin. Their work appears in journals such as Biochemical and Biophysical Research Communications, Experimental Cell Research and Journal of Medical Internet Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026